Related Experiment Video
Updated: Aug 3, 2026

09:43
Measurement of Heme Synthesis Levels in Mammalian Cells
Published on: July 9, 2015
HFE and non-HFE hemochromatosis
Gregory J Anderson1, Lawrie W Powell
1The Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Australia. gregA@qimr.edu.au
International Journal of Hematology
|November 6, 2002
Summary
Hereditary hemochromatosis (HH) is an iron metabolism disorder caused by HFE gene mutations. Identifying the HFE gene improves HH diagnosis and management, though its role in population screening remains debated.
Area of Science:
- Genetics
- Molecular Biology
- Metabolic Disorders
Background:
- Hereditary hemochromatosis (HH) is characterized by excessive dietary iron absorption, leading to organ damage.
- The HFE gene mutation (C282Y) is the primary cause of most HH cases.
- The precise function of the HFE protein in iron regulation is still under investigation.
Purpose of the Study:
- To elucidate the role of the HFE gene in iron metabolism and hereditary hemochromatosis.
- To understand the molecular mechanisms underlying iron homeostasis and its dysregulation in HH.
- To assess the impact of HFE identification on diagnostic capabilities and patient management.
Main Methods:
- Genetic analysis of the HFE gene in individuals with hereditary hemochromatosis.
- Biochemical assays to investigate HFE protein function in iron uptake regulation.
- Clinical evaluation of diagnostic and screening strategies for HH.
Main Results:
- The HFE gene mutation is strongly associated with hereditary hemochromatosis.
- HFE protein, likely with beta2-microglobulin and transferrin receptor 1, regulates duodenal iron absorption.
- HFE identification has enhanced HH diagnosis, family screening, and management of iron overload in liver disease.
Conclusions:
- The discovery of the HFE gene has significantly advanced the understanding of iron metabolism and HH.
- HFE testing has improved clinical practice but its use in general population screening requires further consideration.
- Non-HFE related forms of HH highlight the complexity of iron homeostasis and the need for continued research.
More Related Videos
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Lifecycle of Erythrocytes
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...

